Absorbable Heart Stent Market Share, Growth, and Industry Analysis, By Type (Polymer Absorbable Heart Stent, Metal Absorbable Heart Stent, Absorbable Heart Stent), By Application (Metal, Cardiac Centres, Other) Regional Forecast to 2028

Updated On: 08 April 2024

REPORT OVERVIEW

• 

• Request a Free Sample to learn more about this report

The global absorbable heart stent market size was USD 272.9 million in 2022. As per our research, the market is projected to touch USD 402.7 million by the end of 2028, exhibiting a CAGR of 6.7% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market growth and demand returning to pre-pandemic levels.

The absorbable heart stent market pertains to biodegradable coronary stents that dissolve over time. Unlike permanent metal stents, these stents gradually vanish, potentially reducing long-term complications and obviating the need for prolonged medication. This evolving sector encompasses manufacturers, researchers, and healthcare providers, with material advancements and patient suitability being key factors. Challenges include costs, regulations, and evidence collection. The absorbable heart stent market growth is driven by improved materials and the growing prevalence of heart conditions, heralding a transformative shift in coronary care. Ongoing collaboration and research are pivotal for maximizing absorbable stents' benefits and advancing cardiovascular treatment.

COVID-19 Impact: Pandemic Affected the Market Negatively Owing To the Disruptions in Global Supply Chains

The absorbable heart stent market share has encountered significant challenges due to the COVID-19 pandemic. Disruptions in global supply chains, reduced hospital capacities, and prioritization of urgent cases have collectively impeded the market's growth. Delayed elective procedures and decreased patient visits have led to decreased stent implantations, affecting revenue streams. Moreover, the focus on pandemic-related research has diverted resources from stent innovation. However, as healthcare systems adapt and recover, the market could rebound, driven by the ongoing need for advanced cardiac care. Continued collaboration, telemedicine integration, and adaptable strategies are pivotal for the market to navigate these unprecedented times and regain momentum.

LATEST TRENDS

"Personalized Treatment Strategies to Enhance Market Growth"

In the absorbable heart stent market, a noteworthy trend gaining traction is the shift toward personalized treatment strategies. This trend leverages advances in medical imaging, computational modelling, and patient data analytics to tailor absorbable stent interventions to individual patients. By considering factors like artery size, plaque composition, and patient's overall health, healthcare providers can optimize stent selection and placement. Personalized approaches not only enhance procedural success but also reduce complications and improve long-term outcomes. This trend reflects a broader movement towards precision medicine, fostering a new era in interventional cardiology where absorbable stents are uniquely positioned to transform patient care and cardiovascular health.

SEGMENTATION

• 

• Request a Free Sample to learn more about this report

• By Type

Based on type, the market is classified as polymer absorbable heart stent, metal absorbable heart stent, and absorbable heart stent

• By Application

Based on application, the market is classified as metal, cardiac centres, other

DRIVING FACTORS

"Shift towards Shorter Dual Antiplatelet Therapy (DAPT) Durations to Fuel the Market Demand"

A significant driving force behind the growing demand for the market is the evolving approach to dual antiplatelet therapy (DAPT). Unlike traditional metallic stents that require prolonged DAPT to prevent clot formation, absorbable stents' unique design allows for a shorter DAPT duration. This appeals to both patients and healthcare providers, as it reduces the risk of bleeding complications while maintaining effective treatment. The ability to strike a balance between preventing clots and minimizing bleeding events is steering the market towards absorbable stents as a preferred choice in coronary interventions.

"Advancements in Interventional Imaging Technologies to Spur the Market Demand"

The continuous evolution of interventional imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is spurring the demand for this market. These advanced imaging techniques provide detailed insights into the arterial structure and stent deployment, enabling precise placement and optimization of stent selection. As absorbable stents require accurate placement due to their gradual resorption, the synergy between these imaging tools and the stent technology enhances procedural success rates and contributes to the overall positive patient experience.

RESTRAINING FACTOR

"Clinical Evidence and Long-Term Data Are Key Restraining Factors Impacting the Wide-Scale Adoption"

The broader adoption of the stent faces a significant restraining factor in the form of limited clinical evidence and long-term data. While the concept of stents that gradually dissolve holds promise, the medical community and regulatory bodies emphasize the importance of substantial clinical trials and extended follow-up periods to ascertain their safety and efficacy over time. The lack of comprehensive long-term data may lead to hesitancy among healthcare professionals and potential patients, slowing down the widespread integration of absorbable stents into standard practice. Addressing this restraint necessitates continued robust research, extensive clinical trials, and transparent dissemination of outcomes to build the necessary confidence in the technology's reliability and patient benefits.

REGIONAL INSIGHTS

• 

• Request a Free Sample to learn more about this report

"Europe to Dominate the Market Due To the Increase in Infrastructural Development"

Europe emerges as a pivotal driver in the absorbable heart stent market share due to its advanced healthcare infrastructure, rigorous regulatory environment, and clinical research excellence. Nations like Germany, the U.K., and France contribute significantly to innovation and evidence generation, fostering confidence among healthcare professionals and patients. With a rising burden of cardiovascular diseases, Europe's emphasis on patient outcomes aligns well with the benefits of absorbable stents, solidifying its dominant role in shaping the trajectory of this transformative medical technology.

KEY INDUSTRY PLAYERS

"Financial Players to Contribute Towards Expansion of the Market Owing To the Development and Commercialization"

Financial players are set to play a pivotal role in driving the expansion of the market. Investors, venture capitalists, and financial institutions recognize the promising potential of innovative technologies, such as heart stents, and are keen to invest in their development and commercialization. Their capital infusion facilitates research and development efforts, clinical trials, manufacturing scale-up, and market penetration. Moreover, financial backing supports the establishment and growth of start-ups and companies specializing in it. This influx of funds accelerates product advancement, regulatory approvals, and global distribution. As financial players contribute crucial resources, the absorbable heart stents market gains momentum, ultimately benefiting patients by offering safer, more effective cardiovascular interventions.

List of market players profiled

• Abbott Laboratories (Illinois)
• Biotronik (Berlin)
• Arterial Remodeling Technologies (France)
• Amaranth Medica (India)
• Kyoto Medical Planning (Japan)
• Elixir Medical Corporation (California)
• Reva Medical (California)

REPORT COVERAGE

The evolution of this market marks a significant stride in the realm of cardiovascular interventions. These innovative devices, designed to gradually dissolve in the body, offer the promise of reduced long-term complications and improved patient outcomes. As the market unfolds, it is clear that multiple driving forces shape its trajectory.

Regions like Europe, with its advanced healthcare infrastructure, clinical research excellence, and stringent regulations, stand out as key influencers. Their commitment to patient-centred care and innovation has propelled these heart stents to the forefront of cardiovascular treatment.

In navigating challenges, such as the need for long-term clinical evidence, collaboration remains pivotal. The collective efforts of healthcare professionals, researchers, regulatory bodies, and financial players will propel absorbable heart stents toward a future where safer, more personalized, and effective cardiovascular care becomes a reality for patients worldwide. As the journey continues, this innovative technology holds the promise of transforming lives and enhancing the landscape of cardiac interventions.